AAAAAA
Results:
1-10
|
Results: 10
Authors:
CELIK I
KARS A
GULER N
BARISTA I
TEKUZMAN G
OZYILKAN O
HAYRAN M
FIRAT D
Citation: I. Celik et al., PHASE-II TRIAL OF MINE AS A FRONT-LINE THERAPEUTIC MODALITY IN INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS, European journal of cancer, 34(5), 1998, pp. 759-760
Authors:
YALCIN S
KARS A
OZISIK Y
TEKUZMAN G
OZYILKAN O
CELIK I
BARISTA I
GULLU I
GULER N
BALTALI E
FIRAT D
Citation: S. Yalcin et al., VB-CHEP CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS, European journal of haematology, 61(4), 1998, pp. 261-265
Authors:
OZYILKAN O
BALTALI E
OZDEMIR O
TEKUZMAN G
KIRAZLI S
FIRAT D
Citation: O. Ozyilkan et al., HEMOSTATIC CHANGES - PLASMA-LEVELS OF ALPHA2-ANTIPLASMIN-PLASMIN COMPLEX AND THROMBIN-ANTITHROMBIN-III COMPLEX IN FEMALE BREAST-CANCER, Tumori, 84(3), 1998, pp. 364-367
Authors:
OZYILKAN O
BALTALI E
TEKUZMAN G
FIRAT D
Citation: O. Ozyilkan et al., THE IMPACT OF DIAGNOSIS AND TREATMENT ON THE QUALITY-OF-LIFE IN BREAST-CANCER PATIENTS, Neoplasma, 45(1), 1998, pp. 50-52
HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS-INFECTIONS IN TURKISH PATIENTS WITH HEPATOCELLULAR-CARCINOMA
Authors:
OZYILKAN O
ARSLAN M
OZYILKAN E
Citation: O. Ozyilkan et al., HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS-INFECTIONS IN TURKISH PATIENTS WITH HEPATOCELLULAR-CARCINOMA, The American journal of gastroenterology, 91(7), 1996, pp. 1479-1480
Authors:
OZDAMAR SO
OZYILKAN E
OZYILKAN O
KANDEMIR B
Citation: So. Ozdamar et al., THE CORRELATION BETWEEN P53 TUMOR-SUPPRESSOR GENE AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSIONS IN COLORECTAL ADENOCARCINOMA, Pathology international, 45(12), 1995, pp. 973-974
Authors:
GULER N
BALTALI E
KARS A
OZISIK Y
ENUNLU T
TEKUZMAN G
OZYILKAN O
ONAT D
GULLU I
BARISTA I
FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70
Authors:
OZYILKAN O
OZYILKAN E
KARAGOZ F
OZDAMAR S
KANDEMIR B
Citation: O. Ozyilkan et al., HEPATITIS-C VIRUS-INFECTION AND ANGIOIMMUNOBLASTIC LYMPHADENOPATHY, The American journal of gastroenterology, 90(6), 1995, pp. 1029-1030
Authors:
TOPELI A
OZYILKAN O
OZYILKAN E
KARS A
FIRAT D
Citation: A. Topeli et al., PREVALENCE OF HEPATITIS-C, HEPATITIS-B AND HEPATITIS-D MARKERS IN CANCER-PATIENTS IN TURKEY, European journal of clinical microbiology & infectious diseases, 13(1), 1994, pp. 38-40
Authors:
OZYILKAN E
OZYILKAN O
FIRAT D
TELATAR H
Citation: E. Ozyilkan et al., HEPATITIS-C VIRUS-ANTIBODY IN PATIENTS WITH PRIMARY LIVER-CANCER (HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA) IN JAPAN, Cancer, 73(7), 1994, pp. 2002-2003
Risultati:
1-10
|